Publication | Closed Access

Evidence of NTRK1 Fusion as Resistance Mechanism to EGFR TKI in EGFR+ NSCLC: Results From a Large-Scale Survey of NTRK1 Fusions in Chinese Patients With Lung Cancer

OncologyNtrk1 FusionMedicinePathologyResistance MechanismCancer BiologyCancer GeneticsMolecular DiagnosticsCell BiologyLung CancerMolecular Oncology